Jentadueto (linagliptin / metformin) is a combination medication used along with a healthy diet and exercise to treat Type 2 diabetes. It's taken by mouth, either once or twice daily, depending on the formulation your provider prescribes (immediate-release or extended-release). Both formulations of Jentadueto (linagliptin / metformin) need to be taken with food to prevent stomach upset. Some of the more common side effects of this medication include diarrhea, cough, and runny or stuffy nose.
Type 2 diabetes in adults
Jentadueto (linagliptin / metformin) is a combination of two medications.
Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by blocking DPP-4, a protein that breaks down certain hormones in your body. These hormones normally tell your body to make more insulin and produce less sugar. When DPP-4 causes these hormone levels to drop, you end up having high blood sugar levels. By blocking the action of DPP-4, linagliptin helps your body produce more insulin and make less sugar. In doing so, linagliptin helps lower your blood sugar levels.
Metformin is a biguanide that lowers blood sugar in several ways. It lowers the amount of sugar that your liver makes. It also makes your body more sensitive to the effects of insulin. When your body is able to use insulin better, it can move more blood sugar into your cells to use as energy. In addition, metformin lowers the amount of sugar that gets absorbed through your intestines. As a result of these three pathways, metformin helps lower the amount of sugar in your bloodstream.
Source: DailyMed
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Less common
blurred vision
chills
cold sweats
confusion
cool, pale skin
dizziness
fast heartbeat
headache
increased hunger
loss of consciousness
nightmares
seizures
shakiness
slurred speech
unusual tiredness or weakness
Incidence not known
darkened urine
fainting spells
indigestion
irregular heartbeat
large, hard skin blisters
large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
loss of appetite
pains in the stomach, side, or abdomen, possibly radiating to the back
severe joint pain
vomiting
yellow eyes or skin
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
excess air or gas in the stomach or intestines
feeling of fullness
lack or loss of strength
muscle aches
passing gas
stuffy or runny nose
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Combines two medications into one pill for convenience
Taken once or twice daily, depending on which formulation you take
Taken by mouth
Need to take with meals
Not safe for use in people with moderate-to-severe kidney disease
More likely to cause high levels of acid compared to some other medications for diabetes
Take Jentadueto (linagliptin / metformin) with food. The metformin in this medication can cause stomach problems, including diarrhea, nausea, vomiting, and belly pain. So food can help lower the risk of these side effects.
While you're taking Jentadueto (linagliptin / metformin), make sure to drink enough fluids to keep hydrated, especially if you're experiencing vomiting or diarrhea or feeling ill. These conditions can lead to dehydration and raise your risk of having a buildup of lactic acid in your blood.
If you're scheduled for a surgery, let your primary care provider know ahead of time. They can discuss with you when to stop Jentadueto (linagliptin / metformin) before surgery and when to restart this medication afterwards. This is because you might not be able to eat or drink during the time around your surgery, which can raise your risk of lactic acidosis.
Talk with a provider or radiologist about your medication history before getting any procedures done. The contrast dyes that are used for certain imaging procedures can temporarily affect your kidneys. If you're taking Jentadueto (linagliptin / metformin), this effect on the kidneys can raise your risk of metformin buildup in your body and lactic acidosis, which can be dangerous. Don't restart this medication until your provider checks your kidney health to make sure it's safe for you to do so.
If you feel cold in your hands or feet, dizzy, weak, confused, or nauseous or have trouble breathing, belly pain, or a racing heart, stop taking Jentadueto (linagliptin / metformin) and get medical attention right away. These can be signs of a serious condition called lactic acidosis (high acid levels in the blood), which sometimes can require treatment in the hospital.
Jentadueto (linagliptin / metformin) can interact with certain medications. For example, ranolazine (Ranexa), a medication used to treat chest pain, can expose your body to more metformin, which raise your risk of lactic acidosis. Let your provider or pharmacist know what medications you're taking, including over-the-counter products and supplements, before you start Jentadueto (linagliptin / metformin).
Make sure to get your routine blood tests done on time while you’re taking Jentadueto (linagliptin / metformin). By doing so, your provider can check for side effects, like liver injury or changes to your vitamin B12 levels, or your risk for lactic acidosis (too much acid in your blood). This makes sure Jentadueto (linagliptin / metformin) is safe for you to take.
It's important to eat healthy and exercise regularly to keep your blood sugar under control. Make sure to work with your provider on a diet and exercise plan while taking Jentadueto (linagliptin / metformin).
Jentadueto (linagliptin / metformin) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Kidney or liver problems | Heart failure or heart attack | Age 65 or older | Not eating food or fasting before surgery | Excessive alcohol use | Imaging procedure using contrast dye | Taking certain medications that affect the kidneys
Metformin in Jentadueto (linagliptin / metformin) can cause a rare, but serious medical condition called lactic acidosis (too much lactic acid in your blood). If left untreated, this condition can lead to other health problems, including organ failure, which can be deadly. Discuss with your primary care provider about your medical history before starting Jentadueto (linagliptin / metformin) and any planned procedures during treatment. They can check for your risk for lactic acidosis. Get medical attention immediately if you experience trouble breathing, irregular heartbeat, muscle pain, belly pain, or feeling very tired or dizzy. These can be signs that you have too much lactic acid in your blood.
Though rare, people who took linagliptin in clinical studies have reported having inflammation of the pancreas (pancreatitis). It's not known if Jentadueto (linagliptin / metformin) can raise your risk of pancreatitis if you've had this problem before. Some common symptoms of an inflamed pancreas are upper stomach pain, fever, nausea, and vomiting. If you start to feel any of these symptoms, contact your provider right away. You might need to stop taking Jentadueto (linagliptin / metformin).
Risk factors: Heart failure | Heart problems | Kidney problems
If you've recently had a heart or kidney problem, let your provider know before starting Jentadueto (linagliptin / metformin). Though rare, people who took medications similar to linagliptin have developed heart failure. But it's unclear whether Jentadueto (linagliptin / metformin) carries this same risk and more research is needed in this area. Let your provider know right away if you experience any symptoms of heart failure, such as trouble breathing, tiredness, swelling in your body, or sudden weight gain. Your provider might recommend that you go to the hospital and that you stop taking Jentadueto (linagliptin / metformin).
Risk factor: History of allergy to DPP-4 inhibitors (also called "gliptins")
Jentadueto (linagliptin / metformin) might cause serious allergic reactions, such as rash, peeling or blistering skin, swelling, trouble breathing, and dizziness. Let your provider know if you've had an allergic reaction to other DPP-4 inhibitors or "gliptins", such as Januvia (sitagliptin) or Tradjenta (linagliptin). Though unclear, it's possible that taking Jentadueto (linagliptin / metformin) might cause you to have another allergic reaction. If you experience an allergic reaction to Jentadueto (linagliptin / metformin), stop the medication and get medical care right away.
Risk factors: Long-term use of metformin | Lower than average calcium or vitamin B12 intake
Taking diabetes medications that contain metformin, including Jentadueto (linagliptin / metformin), for a long period of time can cause your vitamin B12 levels to drop. Having low vitamin B12 levels can lead to a higher risk of anemia. Your provider will check your vitamin B12 levels through blood work every 2 to 3 years. If needed, your provider might recommend that you take vitamin B12 supplementation. Let your provider know if you frequently have low energy, dizziness, muscle problems, or tingling or numbness in your hands and feet.
People who take diabetic medications similar to linagliptin in Jentadueto (linagliptin / metformin) have experienced severe joint pain. This can happen anytime from a day to many years after starting the medication. For most people, the pain goes away after they stop the medication. If you experience any discomfort in your joints, speak to your provider right away.
Some people taking Jentadueto (linagliptin / metformin) have experienced an itchy, blistering rash (bullous pemphigoid). Typically, the blisters or sores go away once you stop taking the medication. If you have itchy skin, rash with blisters, or sores, talk to a provider right away and stop taking Jentadueto (linagliptin / metformin).
Jentadueto (linagliptin / metformin): The typical starting dose is 2.5 mg/500 mg (linagliptin / metformin) by mouth twice daily with food. The maximum dose is 2.5 mg/1000 mg (linagliptin / metformin) twice daily.
Jentadueto (linagliptin / metformin) XR: The typical starting dose is 5 mg/1000 mg (linagliptin / metformin) by mouth once daily with food. The maximum dose is 5 mg/2000 mg (linagliptin / metformin) once daily.
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Severe kidney problems
Sudden or long-term acidosis (dangerously high levels of acid), including diabetic ketoacidosis
History of allergic reaction to Tradjenta (linagliptin) or metformin
Type 2 diabetes in adults
Type 2 diabetes in adults
Type 2 diabetes in adults (when taken along with nutritious diet and regular exercise)
Lowers risk of death from heart problems in adults with Type 2 diabetes and heart disease
By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men’s health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.
American Kidney Fund. (2023). Stages of kidney disease (CKD).
Boehringer Ingelheim Pharmaceuticals, Inc. (2023). JENTADUETO XR- linagliptin and metformin hydrochloride tablet, film coated, extended release [package insert]. DailyMed.
Boehringer Ingelheim Pharmaceuticals, Inc. (2023). JENTADUETO- linagliptin and metformin hydrochloride tablet, film coated [package insert]. DailyMed.
Centers for Disease Control and Prevention. (2022). Get active!
Klochkov, A., et al. (2023). Alcoholic pancreatitis. StatPearls.
MedlinePlus. (2023). Dehydration.
MedlinePlus. (2022). Lactic acidosis.
National Heart, Lung, and Blood Institute. (2022). Vitamin B12–deficiency anemia.
White, W.B., et al. (2013). Alogliptin after acute coronary syndrome in patients with type 2 diabetes. The New England Journal of Medicine.
You and Your Hormones. (2021). Insulin.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.